Release of tritiated agmatine from spinal synaptosomes

NeuroReport

Volumn 17, Issue 1, 2006, Pages 13-17

  Goracke Postle, Cory J ^a   Nguyen, Hoang Oanh X ^a   Stone, Laura S ^a   Fairbanks, Carolyn A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Arginine; Neuromodulator; Neurotransmitter; Polyamine; Spinal cord

Indexed keywords

AGMATINE; CALCIUM ION; NEUROTRANSMITTER; POLYAMINE; POTASSIUM; SYNAPTOPHYSIN; SYNAPTOTAGMIN;

ANIMAL CELL; ARTICLE; BRAIN FUNCTION; DEPOLARIZATION; IMMUNOREACTIVITY; MALE; NERVE ENDING; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; SPINE; SYNAPTOSOME; TEMPERATURE;

AGMATINE; ANALYSIS OF VARIANCE; ANIMALS; CALCIUM; D-ASPARTIC ACID; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOHISTOCHEMISTRY; MALE; POTASSIUM CHLORIDE; RATS; SPINAL CORD; SYNAPTOPHYSIN; SYNAPTOSOMES; SYNAPTOTAGMINS; TEMPERATURE; TIME FACTORS; TRITIUM;

EID: 29344447039     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnr.0000192739.38653.aa     Document Type: Article

References (25)

1. Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ. Agmatine: an endogenous clonidine-displacing substance in the brain [see comments]. Science 1994; 263:966-969.
2. Yang XC, Reis DL. Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J Pharmacol Exp Ther 1999; 288:544-549.
3. Fairbanks CA, Schreiber KL, Brewer KL, Yu CG, Stone LS, Kitto KF, et al. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci USA 2000; 97:10584-10589.
4. Galea E, Regunathan S, Eliopoulos V, Feinstein DL, Reis DJ. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem J 1996; 316:247-249.
5. Demady DR, Jianmongkol S, Vuletich JL, Bender AT, Osawa Y. Agmatine enhances the NADPH oxidase activity of neuronal NO synthase and leads to oxidative inactivation of the enzyme. Mol Pharmacol 2001; 59:24-29.
6. Nguyen HO, Goracke-Postle CJ, Kaminski LL, Overland AO, Morgan AD, Fairbanks CA. Neuropharmacokinetic and dynamic studies of agmatine. Ann NY Acad Sci 2003; 1009:82-105.
7. Reis DJ, Regunathan S. Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci 2000; 21:187-193.
8. Yoshikami D. Transmitter sensitivity of neurons assayed by autoradiography. Science 1981; 212:929-930.
9. Sastre M, Regunathan S, Reis DJ. Uptake of agmatine into rat brain synaptosomes: possible role of cation channels. J Neurochem 1997; 69: 2421-2426.
10. Fried G, Franck J, Brodin E, Born W, Fischer JA, Hiort W, et al. Evidence for differential storage of calcitonin gene-related peptide, substance P and serotonin in synaptosomal vesicles of rat spinal cord. Brain Res 1989; 499:315-324.
11. Schmid G, Bonanno G, Raiteri M. Functional evidence for two native GABAA receptor subtypes in adult rat hippocampus and cerebellum. Neuroscience 1996; 73:697-704.
12. Raiteri L, Stigliani S, Zappettini S, Mercuri NB, Raiteri M, Bonanno G. Excessive and precocious glutamate release in a mouse model of amyotrophic lateral sclerosis. Neuropharmacology 2004; 46:782-792.
13. Ramanathan M, Kuo HR, Lambert CW, Ingoglia NA. Introduction of macromolecules into synaptosomes using electroporation. J Neurosci Methods 2000; 96:19-23.
14. Canton T, Pratt J, Stutzmann JM, Imperato A, Boireau A. Glutamate uptake is decreased tardively in the spinal cord of FALS mice. Neuroreport 1998; 9:775-778.
15. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995; 38:73-84.
16. Pittaluga A, Fedele E, Risiglione C, Raiteri M. Age-related decrease of the NMDA receptor-mediated noradrenaline release in rat hippocampus and partial restoration by D-cycloserine. Eur J Pharmacol 1993; 231:129-134.
17. 2+-dependent release of norepinephrine from permeabilized nerve terminals. Neurochem Res 1999; 24:733-738.
18. Fassio A, Sala R, Bonanno G, Marchi M, Raiteri M. Evidence for calcium-dependent vesicular transmitter release insensitive to tetanus toxin and botulinum toxin type F. Neuroscience 1999; 90:893-902.
19. Marchi M, Raiteri M. On the presence in the cerebral cortex of muscarinic receptor subtypes which differ in neuronal localization, function and pharmacological properties. J Pharmacol Exp Ther 1985; 235:230-233.
20. Bonanno G, Sala R, Cancedda L, Cavazzani P, Cossu M, Raiteri M. Release of dopamine from human neocortex nerve terminals evoked by different stimuli involving extra- and intraterminal calcium. Br J Pharmacol 2000; 129:1780-1786.
21. Raiteri M, Bonanno G, Marchi M, Maura G. Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors? J Pharmacol Exp Ther 1984; 231:671-677.
22. Bonanno G, Maura G, Raiteri M. Pharmacological characterization of release-regulating serotonin autoreceptors in rat cerebellum. Eur J Pharmacol 1986; 126:317-321.
23. Levi G, Bertollini A, Chen J, Raiteri M. Regional differences in the synaptosomal uptake of 3H-gamma-aminobutyric acid and 14C-glutamate and possible role of exchange processes. J Pharmacol Exp Ther 1974; 188:429-438.
24. Carpenedo R, Pittaluga A, Cozzi A, Attucci S, Galli A, Raiteri M, et al. Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur J Neurosci 2001; 13:2141-2147.
25. Baranano DE, Ferris CD, Snyder SH. Atypical neural messengers. Trends Neurosci 2001; 24:99-106.